Company Overview

Development Stage

About the Company

[Summary] Make thousands of Chinese children healthy and strong

Founded in 1994, Dyne Pharmaceuticals is the first chairman unit of the Pediatric Drug Professional Committee of the China Pharmaceutical Enterprise Management Association. With the mission of "making thousands of Chinese children healthy and strong" and the strategic goal of "becoming a leading enterprise in the field of children's healthcare and treatment," the company focuses on the research, development, production, and sales of products for children's health.

Dyne Pharmaceuticals has always adhered to the research concept of "customizing children's drugs," actively carried out innovative research and development of pediatric drugs, and built the first domestic R&D center for pediatric drugs. It has successively been approved to establish national enterprise technology centers, Shandong Provincial Children's Drug Technology Innovation Center, Shandong Provincial Children's Drug Formulation Engineering Research Center, and postdoctoral innovation practice bases and other scientific research and talent platforms. The company has filed a total of 140 national patents and 8 PCT international patents, and has undertaken 6 national-level projects including the "13th Five-Year" major new drug creation special projects and 15 provincial key projects.

Dyne Pharmaceuticals has gained a good reputation and coverage in the field of professional pediatric medications. Since 2013, it has been awarded the title of "Top 100 Comprehensive Strength Enterprises in China's Chemical Pharmaceutical Industry" consecutively, and has been honored as one of the "China's 100 Outstanding Pharmaceutical Enterprises," "Shandong Pharmaceutical Industry's Most Powerful Enterprise," and "Pharmaceutical Industry Benchmark Enterprise for the 70th Anniversary of the Founding of New China." Its star product, Yikexin (Vitamin A and D Drops Capsule Type), has achieved annual sales exceeding 2.5 billion yuan and has maintained a leading position in the market for more than 20 consecutive years, winning numerous professional awards and honors such as "Innovative Technology Model Brand," "Pediatric Drug Product Brand in China's Chemical Pharmaceutical Industry," and "Excellent OTC Product Brand in China's Chemical Pharmaceutical Industry." In May 2024, Yikexin was awarded a brand value of 3.714 billion yuan in the "China Brand Value Evaluation Information Release" by the China Brand Building Promotion Association.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Dyne Pharmaceuticals How Fast Is Hiring Growing? (185 open positions)

Manage
Note: How fast is hiring at Shandong Dyne Marine Biopharmaceutical Co., Ltd. growing? Dyne Pharmaceuticals2025: 283 openings (up 8%), 2024: 261 openings (up 187%), 2023: 91 openings (up 18%), 2022: 77 openings (down 62%), 2021: 200 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Dyne Pharmaceuticals Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Down 67%
  • 2024: Up 300%
  • 2023: Up 200%
  • 2022: Down 67%
Dyne Pharmaceuticals Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Shandong Dyne Marine Biopharmaceutical Co., Ltd. growing? Dyne PharmaceuticalsMaster's recruitment over the years: 2025: 4 openings (down 67%), 2024: 12 openings (up 300%), 2023: 3 openings (up 200%), 2022: 1 openings (down 67%), 2021: 3 openings.

Dyne Pharmaceuticals Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
Dyne Pharmaceuticals Doctoral Hiring by Year: 2024 — same as 2023
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Shandong Dyne Marine Biopharmaceutical Co., Ltd. growing? Dyne PharmaceuticalsDoctorate recruitment over the years: 2024: 1 openings (up 300%), 2023: 1 openings (up 200%), 2022: 1 openings (down 67%), 2021: 1 openings.

Dyne Pharmaceuticals R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Shandong Dyne Marine Biopharmaceutical Co., Ltd.? Based on an analysis of Dyne Pharmaceuticals's job postings over the past year, "计算机/网络/技术类" demand: 9.9%, "医疗卫生/美容保健类": 9.6%, "生物/制药/化工/环保类": 9.1%, "咨询/顾问类": 5%, "其他(研发和技术类)": 2.3%, "科研类": 1.2%. For reference only.

Dyne Pharmaceuticals — What Are the Salaries Like? (342 records)

Manage
salary range: 2K - 50K, 85.1% of roles pay ¥10-50K
Note: salary statistics are based on 342 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Shandong Dyne Marine Biopharmaceutical Co., Ltd.?Dyne Pharmaceuticals85.1% of positions earn 10-50K, Fresh graduate salary: ¥6.4K。Weihai salary ranking top 10,销售类 average salary ¥16.4K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Dyne Pharmaceuticals

(More)
Are salaries high at Shandong Dyne Marine Biopharmaceutical Co., Ltd.? We provide: 医药代表,otc代表,运营,销售,临床,渠道,培训,市场,bd,产品经理,实习生,管培生,销管,招商,推广,品牌,商务代表,组长,店长,营销经理. Click to view detailed salary analysis by job.

Dyne Pharmaceuticals honors, qualifications & industry associations

Dyne Pharmaceuticals Related Industry Tags

Job Category

  • 销售类
    71.7% of total 71.7%
  • 经营管理类
    25.1% of total 25.1%
  • 客户服务类
    15.6% of total 15.6%
  • 市场/公关/媒介类
    15.6% of total 15.6%

Education

  • 大专
    62.4% of total 62.4%
  • 本科
    29.5% of total 29.5%
  • 硕士
    5.2% of total 5.2%
  • 不限
    2.9% of total 2.9%

Experience

  • 3-5年
    30.3% of total 30.3%
  • 1-3年
    28.6% of total 28.6%
  • 5-10年
    18.5% of total 18.5%
  • 不限
    17.6% of total 17.6%
View Detailed Analysis

What does Shandong Dyne Marine Biopharmaceutical Co., Ltd. require? Who is Dyne Pharmaceuticals hiring? Dyne Pharmaceuticals recruitment: 销售类占比最多占71.7%,其次是经营管理类占25.1%. What education can get in at Dyne Pharmaceuticals? 大专占比最多占62.4%,其次是本科占29.5%. High education required at Dyne Pharmaceuticals? 硕士占5.2%. Work experience required at Dyne Pharmaceuticals? 3-5年占比最多占30.3%,其次是1-3年占28.6%. Where are the job locations at Dyne Pharmaceuticals? 北京占比最多占32.1%,其次是广州占8.7%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 6,200万(元)
Legal Representative: 朱效平
Date Established:
Credit Code: 913700006137729862
Registered Address: 山东省荣成市富源南路18号

Dyne Pharmaceuticals Featured in the Following Albums (More)

Partners & Suppliers

线上药品销售合作,达因产品入驻阿里健康平台 Source
合作客户 互联网医疗
线上药品销售合作,达因药业产品入驻京东健康 Source
合作客户 互联网医疗
产学研合作,共建实验室 Source
供应商 学术合作
教学基地与科研合作 Source
供应商 学术合作
联合实验室,共同研发儿童营养药品 Source
供应商 学术合作

People who follow Dyne Pharmaceuticals also follow

Dyne Pharmaceuticals Competitors (Similar Companies)

“Trustworthy overall solution provider for medical systems”
轮胎 轮胎橡胶 特种车 汽车零部件/配件
海底电缆 高压电缆 海缆 研发
特种车 空港设备 无人机 飞行器
水务 水处理 城市供水 水务投资
DHA 鱼胶 胶原蛋白 护肤
制药/药业 医药 医药工业 原料药
条码打印机 智慧金融 智能零售 智慧物流
制药/药业 医药 氨基酸 中成药
多肽 健康科技 新材料 纳米材料
制造 生产 工业 油轮
电子线束 连接线 电源线 控制电缆
“高性能碳纤维及其复合材料、制品”
豆类 甘露醇 农业种植 微量元素
重工 船舶 尾气处理 造船

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates